DNMR logo

Danimer Scientific, Inc. (DNMR) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

DNMR, $ (piyasa değeri 0) fiyatla Basic Materials işi olan Danimer Scientific, Inc.'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 44/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
44/100 AI Puanı

Danimer Scientific, Inc. (DNMR) Malzemeler ve Emtia Maruziyeti

CEORichard N. Altice
Çalışanlar257
MerkezBainbridge, US
Halka Arz Yılı2020

Danimer Scientific, Inc. specializes in developing and producing biodegradable plastic alternatives, primarily polyhydroxyalkanoate (PHA) under the Nodax brand. Targeting consumer packaging and plastics industries, the company offers sustainable solutions to replace traditional petroleum-based plastics, addressing growing environmental concerns and regulatory pressures.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Danimer Scientific presents an investment opportunity within the burgeoning bioplastics market, driven by increasing consumer demand for sustainable packaging and stricter environmental regulations. The company's Nodax PHA offers a biodegradable alternative to traditional plastics, potentially capturing market share as brands seek eco-friendly solutions. However, current financials reveal a negative profit margin of -333.0% and a negative gross margin of -57.7%, indicating significant challenges in achieving profitability. The company's success hinges on scaling production efficiently, securing key partnerships with major consumer brands, and navigating the competitive landscape of bioplastic producers. Investors should closely monitor the company's progress in improving margins and achieving sustainable revenue growth.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Danimer Scientific operates in the bioplastics market, addressing the increasing demand for sustainable alternatives to traditional petroleum-based plastics.
  • The company's core product, Nodax PHA, is a biodegradable plastic feedstock used in various applications, including films, straws, and food containers.
  • Danimer Scientific serves consumer packaging brand owners, converters, and manufacturers in the plastics industry.
  • The company's negative profit margin of -333.0% and gross margin of -57.7% highlight the current challenges in achieving profitability.
  • Danimer Scientific's beta of 1.63 suggests higher volatility compared to the overall market.

Rakipler & Benzerleri

Güçlü Yönler

  • Proprietary Nodax PHA technology.
  • Focus on biodegradable and sustainable materials.
  • Potential for strong growth in the bioplastics market.
  • Established relationships with consumer packaging companies.

Zayıflıklar

  • Negative profit and gross margins.
  • Limited production capacity compared to larger competitors.
  • Reliance on a few key customers.
  • Higher production costs compared to traditional plastics.

Katalizörler

  • Ongoing: Increasing consumer demand for sustainable packaging solutions.
  • Ongoing: Government regulations promoting the use of bioplastics.
  • Upcoming: Potential partnerships with major consumer brands to adopt Nodax PHA.
  • Ongoing: Expansion of production capacity to meet growing demand.
  • Ongoing: Development of new applications for PHA in various industries.

Riskler

  • Ongoing: Negative profit and gross margins indicating financial instability.
  • Potential: Competition from established chemical companies with greater resources.
  • Potential: Fluctuations in raw material prices impacting production costs.
  • Potential: Technological advancements in alternative materials.
  • Potential: Limited liquidity due to trading on the OTC market.

Büyüme Fırsatları

  • Growth opportunity 1: Expanding Production Capacity: Danimer Scientific can increase its market share by expanding its production capacity to meet the growing demand for PHA. Investing in new manufacturing facilities and optimizing existing processes will enable the company to fulfill larger orders and secure long-term contracts with major consumer brands. The bioplastics market is projected to reach $29.7 billion by 2025, providing a substantial opportunity for Danimer Scientific to capitalize on increased production capabilities.
  • Growth opportunity 2: Strategic Partnerships: Forming strategic partnerships with consumer packaging companies and manufacturers can accelerate the adoption of Nodax PHA. Collaborating with established players in the plastics industry will provide Danimer Scientific with access to existing distribution channels and customer networks. These partnerships can also facilitate the development of new applications for PHA and drive innovation in sustainable packaging solutions. Timeline: Ongoing.
  • Growth opportunity 3: New Product Development: Investing in research and development to create new biopolymer formulations and applications can differentiate Danimer Scientific from its competitors. Developing PHA-based solutions for specific industries, such as agriculture or healthcare, can open up new market segments and revenue streams. Focusing on developing high-performance bioplastics with enhanced properties will further strengthen the company's competitive advantage. Timeline: Ongoing.
  • Growth opportunity 4: Government Incentives and Regulations: Capitalizing on government incentives and regulations that promote the use of bioplastics can drive demand for Danimer Scientific's products. Many countries are implementing policies to reduce plastic waste and encourage the adoption of sustainable alternatives. By actively engaging with policymakers and participating in industry initiatives, Danimer Scientific can benefit from these favorable regulatory trends. Timeline: Ongoing.
  • Growth opportunity 5: Global Expansion: Expanding into new geographic markets can diversify Danimer Scientific's revenue base and reduce its reliance on the North American market. Targeting regions with strong environmental awareness and supportive government policies, such as Europe and Asia, can provide significant growth opportunities. Establishing local partnerships and distribution networks in these regions will facilitate market entry and ensure long-term success. Timeline: Ongoing.

Fırsatlar

  • Expanding production capacity to meet growing demand.
  • Forming strategic partnerships with major consumer brands.
  • Developing new applications for PHA in various industries.
  • Benefiting from government incentives and regulations promoting bioplastics.

Tehditler

  • Competition from established chemical companies.
  • Fluctuations in raw material prices.
  • Technological advancements in alternative materials.
  • Economic downturns affecting consumer spending.

Rekabet Avantajları

  • Proprietary Nodax PHA technology offers a biodegradable alternative to traditional plastics.
  • Focus on sustainable bioplastic solutions aligns with growing environmental concerns.
  • Established relationships with consumer packaging companies.
  • Potential for economies of scale as production volume increases.

DNMR Hakkında

Founded in 2004 and headquartered in Bainbridge, Georgia, Danimer Scientific, Inc. is a performance polymer company focused on creating sustainable bioplastic replacements for conventional petroleum-based plastics. The company's core product is polyhydroxyalkanoate (PHA), a biodegradable plastic feedstock alternative marketed under the Nodax brand. This material is utilized in a wide array of plastic applications, including films, straws, food containers, and other packaging solutions. In addition to PHA, Danimer Scientific also produces polylactic acid-based resins for coating disposable paper cups and other biopolymers. The company offers its biopolymers in various forms, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. Danimer Scientific markets its products directly to consumer packaging brand owners, converters, and manufacturers within the plastics industry, positioning itself as a key player in the growing market for sustainable and biodegradable plastic alternatives.

Ne Yaparlar

  • Develops bioplastic replacements for traditional petroleum-based plastics.
  • Produces polyhydroxyalkanoate (PHA) under the Nodax brand.
  • Offers PHA for various plastic applications like films, straws, and food containers.
  • Produces polylactic acid-based resins for coating disposable paper cups.
  • Provides biopolymers in forms like additives, coatings, fibers, and films.
  • Markets products to consumer packaging brand owners and manufacturers.

İş Modeli

  • Develops and manufactures bioplastic materials.
  • Sells biopolymers to consumer packaging companies.
  • Generates revenue through direct sales and partnerships.
  • Focuses on sustainable and biodegradable plastic alternatives.

Sektör Bağlamı

Danimer Scientific operates within the specialty chemicals industry, specifically targeting the bioplastics market. This market is driven by increasing consumer awareness of environmental issues and stricter regulations on single-use plastics. The competitive landscape includes companies like CDELF, ETUGF, GFTRF, GSPI, and HANCF, each offering various bioplastic solutions. The demand for biodegradable and compostable materials is expected to grow, creating opportunities for companies like Danimer Scientific to expand their market share by offering innovative and cost-effective bioplastic alternatives.

Kilit Müşteriler

  • Consumer packaging brand owners seeking sustainable materials.
  • Converters who transform raw materials into finished products.
  • Manufacturers in the plastics industry looking for bioplastic alternatives.
AI Güveni: 71% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Danimer Scientific, Inc. (DNMR) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

DNMR için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

DNMR için Wall Street fiyat hedefi analizi.

MoonshotScore

44/100

Bu puan ne anlama geliyor?

MoonshotScore, DNMR'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Richard N. Altice

CEO

Richard N. Altice serves as the CEO of Danimer Scientific, Inc. His background includes extensive experience in the chemicals and plastics industries. He has held various leadership positions in both public and private companies, focusing on strategic planning, business development, and operational efficiency. Altice's expertise lies in driving growth and innovation within the sustainable materials sector. His leadership is crucial for Danimer Scientific as the company navigates the evolving bioplastics market.

Sicil: Under Richard N. Altice's leadership, Danimer Scientific has focused on expanding its production capabilities and forging partnerships with key players in the consumer packaging industry. He has overseen the commercialization of Nodax PHA and its adoption in various applications. A key milestone has been navigating the company through a challenging financial period while maintaining focus on long-term growth and sustainability goals.

DNMR OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Danimer Scientific may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as those listed on major exchanges like NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Trading volume on the OTC market is generally low, potentially leading to wide bid-ask spreads and difficulty in buying or selling shares at desired prices. The limited liquidity can make it challenging for investors to exit their positions quickly, especially in large quantities. This illiquidity adds to the overall risk profile of the investment.
OTC Risk Faktörleri:
  • Limited financial disclosure increases the risk of investing due to lack of transparency.
  • Low trading volume can lead to price volatility and difficulty in executing trades.
  • OTC Other tier companies may be subject to less regulatory oversight.
  • Potential for fraud or manipulation is higher in the OTC market.
  • Limited access to company information and management.
Durum Tespiti Kontrol Listesi:
  • Verify the company's registration and legal standing.
  • Attempt to obtain any available financial statements, even if unaudited.
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Understand the risks associated with investing in OTC securities.
  • Consult with a financial advisor before making any investment decisions.
  • Check for any regulatory actions or legal disputes involving the company.
Meşruiyet Sinyalleri:
  • Company has a functional website with contact information.
  • Company has been in operation for a reasonable period of time (founded in 2004).
  • Company has a physical headquarters in Bainbridge, Georgia.
  • Company has a stated business purpose and target market.
  • Company has a CEO and management team.

Danimer Scientific, Inc. Hissesi: Cevaplanan Temel Sorular

DNMR için değerlendirilmesi gereken temel faktörler nelerdir?

Danimer Scientific, Inc. (DNMR) şu anda yapay zeka skoru 44/100, düşük puanı gösteriyor. Temel güçlü yan: Proprietary Nodax PHA technology.. İzlenmesi gereken birincil risk: Ongoing: Negative profit and gross margins indicating financial instability.. Bu bir finansal tavsiye değildir.

DNMR MoonshotScore'u nedir?

DNMR şu anda MoonshotScore'da 44/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

DNMR verileri ne sıklıkla güncellenir?

DNMR fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler DNMR hakkında ne diyor?

DNMR için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

DNMR'a yatırım yapmanın riskleri nelerdir?

DNMR için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Negative profit and gross margins indicating financial instability.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

DNMR'ın P/E oranı nedir?

DNMR için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için DNMR'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

DNMR aşırı değerli mi, yoksa düşük değerli mi?

Danimer Scientific, Inc. (DNMR)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

DNMR'ın temettü verimi nedir?

Danimer Scientific, Inc. (DNMR) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is based on the most recent available information.
  • OTC market data may be limited and subject to change.
Veri Kaynakları

Popüler Hisseler